| http://www.w3.org/ns/prov#value | - Lorcaserin is approved as an adjunct therapy to lifestyle modifications, a reduced-calorie diet, and increased physical activity for weight management in patients with either a BMI of 30 or greater, a BMI of 27 to 29.9, and a weight-related, comorbid condition such as type 2 diabetes, hypertension, or dyslipidemia.12
|
